Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3Bijal Shah, Olalekan O. Oluwole, Aaron C. Logan et al.|Leukemia|2025Cited by 35
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3Bijal Shah, Armin Ghobadia, Ryan D. Cassaday et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 33